Literature DB >> 313783

The relevance of 25-hydroxycalciferol measurements in sera of patients with renal failure.

R S Mason, D Moddel, A McElduff, J H Stewart, J F Mahony, S Posen.   

Abstract

Iliac crest biopsies and serum specimens were obtained from 36 non-dialyzed uraemic patients. The mean serum 25-hydroxycalciferol concentration of the patients was lower than that of normal subjects and a significant correlation was found between 25-hydroxycalciferol values and the severity of osteomalacia. Parathyroid osteopathy was significantly correlated with serum immunoreactive parathyroid hormone but not with serum 25-hydroxycalciferol values. While normal serum 25-hydroxycalciferol concentrations in uraemic patients do not exclude the presence of osteomalacia, a low concentration is virtually diagnostic of this disorder.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313783     DOI: 10.1111/j.1445-5994.1979.tb04134.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  2 in total

1.  The treatment of metabolic bone disease.

Authors:  S Posen; P Clifton-Bligh; R S Mason
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

2.  Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology.

Authors:  Y L Chan; A C Alfrey; S Posen; D Lissner; E Hills; C R Dunstan; R A Evans
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.